Boston Scientific Announces a $1.6B Agreement to Acquire Silk Road Medical

Marlborough, MA, June 18, 2024 (PRNewswire) -- In a significant addition to its vascular portfolio, Boston Scientific is aqcuiring Silk Road Medical for approximately $1.6B specializing in non-invasive stroke prevention methods. The deal, adds a novel procedure for treating carotid artery conditions into the Boston Scientific's diverse medical offerings. This strategic acquisition is set to complete later this year, bolstering the company’s growth and enhancing its portfolio with a unique therapeutic approach.

Read full article here.